Status:
COMPLETED
Study of Aripiprazole in Patients With Acute Bipolar Mania
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborating Sponsors:
Otsuka America Pharmaceutical
Conditions:
Bipolar Disorder
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this research study is to confirm the safety and effectiveness of aripiprazole therapy over 12 weeks in subjects with bipolar disorder experiencing symptoms of mania.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subjects with Bipolar I Disorder and a diagnosis of acute mania will be considered for this study.
Exclusion
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
End Date :
January 1 2007
Estimated Enrollment :
615 Patients enrolled
Trial Details
Trial ID
NCT00097266
Start Date
December 1 2004
End Date
January 1 2007
Last Update
November 8 2013
Active Locations (45)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Anaheim, California, United States
2
Local Institution
Cerritos, California, United States
3
Local Institution
Garden Grove, California, United States
4
Local Institution
National City, California, United States